Saturday, October 2, 2021
Highlighting the Significant Strides Made in Friedreich Ataxia Care
NeurologyLive. October 1, 2021. David R. Lynch, MD, PhD, professor of neurology, University of Pennsylvania Perelman School of Medicine, discussed why omaveloxolone’s recent success speaks to the progress made within the FA treatment space.
Subscribe to:
Posts (Atom)